Drug Profile
Renal cancer vaccine - Northwest Biotherapeutics
Alternative Names: Kidney cancer vaccine - Northwest BiotherapeuticsLatest Information Update: 29 Apr 2003
Price :
$50
*
At a glance
- Originator University of California at Los Angeles
- Developer Northwest Biotherapeutics; University of California at Los Angeles
- Class Antineoplastics; Cancer vaccines; Dendritic cell vaccines; Immunotherapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Renal cancer
Most Recent Events
- 29 Apr 2003 Discontinued - Preclinical for Renal cancer in USA (unspecified route)
- 13 Jul 2000 New profile
- 13 Jul 2000 Preclinical development for Renal cancer in USA (Unknown route)